Moreover, chitosan/QD NPs surface-labeled with the HER2 antibody have been used in the targeted delivery of HER2 siRNA to SKBR3 breast cancer cells, which overexpress HER2 [252]. The gene discussed is ERBB2; the disease is breast carcinoma.